Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 150 of 151 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/20/24
End: 01/20/25
Due: 01/20/26
Phase: N/A
Priority: Normal
Start: 06/10/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 03/30/24
Due: 03/30/25
Phase: N/A
Priority: Normal
Start: 02/15/23
End: 02/10/24
Due: 02/10/25
Phase: N/A
Priority: Normal
Start: 07/10/20
End: 12/01/20
Due: 12/01/21
Phase: N/A
Priority: Normal
Start: 04/18/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 10/12/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 04/01/17
End: 01/30/19
Due: 01/30/20
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 03/30/22
Due: 03/30/23
Phase: N/A
Priority: Normal
Start: 07/15/23
End: 05/24/24
Due: 05/24/25
Phase: N/A
Priority: Normal
Start: 09/10/24
End: 05/30/25
Due: 05/30/26
Comparison of SRK-T With Kane Formula for Prediction of Refractive Outcome After Phacoemulsification
Phase: N/A
Priority: Normal
Start: 06/17/21
End: 07/17/22
Due: 07/17/23
Phase: N/A
Priority: Normal
Start: 08/15/24
End: 02/01/25
Due: 02/01/26
Phase: N/A
Priority: Normal
Start: 11/10/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 02/01/23
Due: 02/01/24
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: 07/15/23
End: 06/20/24
Due: 06/20/25
Phase: N/A
Priority: Normal
Start: 07/15/23
End: 11/20/24
Due: 11/20/25
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 07/15/24
Due: 07/15/25
Phase: N/A
Priority: Normal
Start: 04/10/24
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 02/01/23
Due: 02/01/24
Phase: N/A
Priority: Normal
Start: 06/10/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 07/15/24
End: 07/15/25
Due: 07/15/26
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 01/30/25
Due: 01/30/26
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 02/01/24
Due: 02/01/25